HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Arakawa Selected Research

Anti-Allergic Agents (Antiallergic Agents)

1/2017A flavanone derivative from the Asian medicinal herb (Perilla frutescens) potently suppresses IgE-mediated immediate hypersensitivity reactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Arakawa Research Topics

Disease

9Type 2 Diabetes Mellitus (MODY)
01/2020 - 04/2005
5Body Weight (Weight, Body)
01/2020 - 01/2012
3Hyperglycemia
01/2015 - 04/2005
2Albuminuria
01/2022 - 02/2014
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2021
2Hypoglycemia (Reactive Hypoglycemia)
01/2020 - 11/2014
2Inflammation (Inflammations)
10/2018 - 01/2017
2Obesity
01/2017 - 01/2012
1Hypoxia (Hypoxemia)
01/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1Renal Insufficiency (Renal Failure)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Proteinuria
01/2021
1Kidney Diseases (Kidney Disease)
01/2021
1Nephritis
01/2021
1Allergic Rhinitis
01/2017
1Dehydration (Water Stress)
01/2017
1Seasonal Allergic Rhinitis (Hay Fever)
01/2017
1Hypersensitivity (Allergy)
01/2017
1Immediate Hypersensitivity
01/2017
1Leukemia
01/2017
1Glucose Intolerance
04/2015
1Hyperinsulinism (Hyperinsulinemia)
01/2015
1Insulin Resistance
01/2015
1Weight Gain
01/2015
1Hypoalbuminemia
02/2014
1Necrosis
01/2012
1Hereditary Spastic Paraplegia
12/2011
1Diabetes Mellitus
01/2006
1Diabetic Neuropathies (Diabetic Neuropathy)
04/2005
1Cardiomegaly (Heart Hypertrophy)
01/2004
1Myotonic Dystrophy (Dystrophia Myotonica)
03/2003

Drug/Important Bio-Agent (IBA)

10CanagliflozinIBA
01/2022 - 01/2012
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2005
8Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 01/2012
3Sodium-Glucose Transport ProteinsIBA
01/2022 - 04/2015
3SodiumIBA
01/2022 - 01/2012
2AlbuminsIBA
01/2021 - 10/2018
2Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2018
23- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA
01/2020 - 04/2015
2Dipeptidyl-Peptidase IV InhibitorsIBA
12/2016 - 04/2015
2Glucagon-Like Peptide 1 (GLP 1)IBA
09/2015 - 04/2015
2Insulin (Novolin)FDA Link
01/2015 - 11/2014
2SymportersIBA
01/2015 - 01/2012
2Blood Glucose (Blood Sugar)IBA
02/2014 - 01/2006
2T 1095IBA
01/2006 - 04/2005
1CreatinineIBA
01/2022
1CalcineurinIBA
01/2021
1NPHS2 proteinIBA
01/2021
1Puromycin AminonucleosideIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1DesminIBA
01/2021
1nephrinIBA
01/2021
1Prednisolone (Predate)FDA LinkGeneric
01/2021
1glimepiride (Amarel)FDA LinkGeneric
01/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
18-Hydroxy-2'-DeoxyguanosineIBA
10/2018
1flavanoneIBA
01/2017
1Immunoglobulin E (IgE)IBA
01/2017
1Anti-Allergic Agents (Antiallergic Agents)IBA
01/2017
1PolyphenolsIBA
01/2017
1PhytochemicalsIBA
01/2017
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
04/2015
1Pioglitazone (Actos)FDA Link
01/2015
1imidaprilIBA
02/2014
1borrelidinIBA
01/2012
1Proteins (Proteins, Gene)FDA Link
12/2011
1Streptozocin (Streptozotocin)FDA Link
01/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2004
1ThiazolidinedionesIBA
01/2004
12,4-thiazolidinedione (thiazolidinedione)IBA
01/2004
1Protein Kinases (Protein Kinase)IBA
03/2003

Therapy/Procedure

7Glycemic Control
01/2020 - 01/2012
2Therapeutics
01/2020 - 01/2015
2Oral Administration
01/2017 - 02/2014
1Exercise Therapy (Therapy, Exercise)
01/2020